"We're going through a period of robust growth," said Derek Hennecke, chief executive officer and president of Xcelience. "We've added team members to Formulation, Preformulation and Analytical, as well as growing our new CSS division. We're also exploring new growth in commercial development with three projects on track to produce registration batches next year."
The CSS facility has produced well more than one hundred batches and introduced a new blister and bottling line in January 2013. Mr. Hennecke added, "The 28 new team members we've added in the last year have brought fresh ideas and new efficiencies to the business. As CEO I've learned that the best thing I can do is hire top talent and then get out of their way."
"I can't tell you how exciting it has been to show clients and potential clients our CSS capabilities and services," says Clinical Packaging Manager, Damian Gant. "We are the only CDMO specifically targeting the clinical supplies market with a small-scale flexible service. Other companies have tried to scale down large production facilities to produce for this market, but scaling down is a bit like driving an RV to work. A large company can do the job, but it's expensive, inflexible, inefficient, and frankly, not cut out for the job. The growth potential within this market is tremendous."
Xcelience will be at table #20 at Contract Pharma's Contracting & Outsourcing Conference & Tabletop Exhibition on Sept. 19! For more information, visit the conference site!